Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV A Study of Immunologic Safety for Alphanate in Previously Treated Patients Diagnosed With Severe Hemophilia A

NCT00323856 is registered in ClinicalTrials.gov with Grifols Biologicals, LLC as lead sponsor.

NCT NCT00323856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00323856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV A Study of Immunologic Safety for Alphanate in Previously Treated Patients Diagnosed With Severe Hemophilia A
Lead sponsor
Grifols Biologicals, LLC
Phase
Phase 4
Overall status
Completed
Start date
April 8, 2003
Completion date
December 14, 2018
Enrollment
51 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

severe hemophilia a